News

Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Research Report 2025 Market To Reach $14.34 Billion By 2034, Driven By Innovative R&D, Strategic Collaborations, And Drug ...
The Europe GLP-1 agonists market, valued at USD 7.09 billion in 2024, is set to grow at a 17.30% CAGR, reaching USD 14.34 billion by 2034. Driven by ...
GLP-1 Agonists Drug Pipeline Analysis Market Report 2025 Next-Generation GLP-1 Agonists Pave The Way For Diabetes And Obesity Management
Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18 ...
Medindia30m
Tirzepatide Slows Breast Cancer Growth in Obese Mice
Tirzepatide reduces breast tumor growth in obese mice while improving metabolic health, offering hope as a dual-action cancer ...
Australian Associated Press40m
Claims about weight loss patch come unstuck
AAP FactCheck - A Facebook page promoting weight loss products is falsely claiming a supposedly New Zealand-made patch has ...